Use of the F-actin-binding drugs, misakinolide A and swinholide A.
Bubb
M R
MR
Department of Medicine, University of Florida College of Medicine, Gainseville 32610, USA.
Spector
I
I
D000199:Actins / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001665:Binding Sites; D002460:Cell Line; D048429:Cell Size / Q000187:drug effects; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D003603:Cytotoxins / Q000494:pharmacology; D004847:Epithelial Cells / Q000187:drug effects; D018942:Macrolides / Q000378:metabolism / Q000494:pharmacology*; D008387:Marine Toxins / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D008856:Microscopy, Fluorescence; D011485:Protein Binding; D012995:Solubility
D000199:Actins; D000970:Antineoplastic Agents; D003603:Cytotoxins; D018942:Macrolides; D008387:Marine Toxins; C104924:bistheonellide A; C086235:swinholide A